CURE Pharmaceutical Holding Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 2.109 million compared to USD 269,000 a year ago. Operating loss was USD 3.265 million compared to USD 13.467 million a year ago. Net loss was USD 1.321 million compared to USD 13.439 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.32 a year ago. For the half year, total revenue was USD 3.555 million compared to USD 549,000 a year ago. Operating loss was USD 7.763 million compared to USD 11.485 million a year ago. Net loss was USD 4.493 million compared to USD 11.392 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.29 a year ago.